Skip to main content
. 2018 Nov 13;13(10-11):1072–1087. doi: 10.1080/15592294.2018.1543503

Table 3.

High-dimensional mediation analysis for the association of BMI z-score in mid-childhood with cardio-metabolic risk score in early adolescence via DNA methylation in mid-childhood (Results of CpG sites selected by sure independence screening criterion and a variable selection technique (minimax concave penalty)).

    Joint significance testa
Leave-one-out
cross-validationb
     
CpG chr αc βd FDR % TEe mean αc mean βd Gene symbol Gene region Relation to Island
cg03205258 22 0.06 0.14 0.53 2.45% 0.06 0.13 TXNRD2;COMT 1stExon;1stExon;5ʹUTR Island
cg01832325 11 0.04 0.15 0.53 2.11% NA NA HBBP1 TSS1500 OpenSea
cg25825612 17 −0.04 −0.17 0.53 1.95% −0.04 −0.14 TBCD Body N_Shelf
cg04967734 11 −0.03 −0.17 0.53 1.85% −0.03 −0.12 DDX10 Body OpenSea
cg22683879 19 0.05 0.09 0.53 1.50% 0.05 0.09 MIR1181;CDC37 TSS200;TSS200 Island
cg14732969 3 −0.06 −0.03 0.53 0.55% NA NA     S_Shore
cg08033383 1 0.01 0.06 0.53 0.24% NA NA FAM40A 1stExon Island
cg08189124 11 0.03 0.25 0.54 2.17% NA NA     N_Shelf
cg06897686 2 0.01 0.33 0.67 1.22% 0.01 0.3 ATOH8 Body Island
cg24780236 7 −0.02 −0.2 0.67 1.14% −0.02 −0.19 TAS2R40 TSS1500 OpenSea
cg05677579 3 0.01 0.11 0.67 0.36% NA NA RRP9;PARP3 TSS1500;TSS200 Island
cg23081542 7 −3.17E-03 −0.18 0.83 0.19% NA NA LOC723809 Body OpenSea
cg01025283 3 −0.05 0.15 0.23 −2.25% −0.05 0.16 FAIM TSS200;5ʹUTR;1stExon Island
cg26494138 2 −0.05 0.24 0.23 −4.18% −0.05 0.20     S_Shore
cg23992886 7 0.02 −0.14 0.54 −0.89% NA NA MET;MET Body;Body OpenSea
cg07026904 11 −0.02 0.06 0.67 −0.42% NA NA     S_Shore
cg23331961 15 0.02 −0.13 0.67 −0.67% 0.02 −0.12 PARP6 TSS1500 N_Shore
cg11631158 13 0.01 −0.09 0.76 −0.43% 0.01 −0.09 SHISA2 Body N_Shore
cg18647237 5 4.50E-04 −0.26 0.98 −0.04% 4.35E-04 −0.20     N_Shore

Abbreviation: false discovery rate (FDR); Body mass index (BMI); BMI z-score (BMIz); DNA methylation (DNAm); the proportion of total effect (% TE)

a In the joint significance test, FDR of the BMIz – DNAm associations (α) and FDR of the DNAm – cardio-metabolic risk score associations (β) were estimated separately, and the larger FDR was reported;

b In the leave-one-out cross-validation, 265 validation tests were performed by excluding one participant from the full dataset. Only the CpGs being selected by the variable selection procedure in more than 95% of the validation tests were reported in this study. Results are the mean coefficients of each CpG in all validation tests;

c Results represent changes of M-value. Adjusted for child sex, maternal education (college graduate), maternal smoking during pregnancy (never, former, during pregnancy), age at blood draw for DNA methylation, and cell type proportions. Batch effect from plate was adjusted in ComBat. BMIz was included in the ComBat model to protect regression variability;

d Results represent changes of M-value. Adjusted for child sex, maternal education (college graduate), maternal smoking during pregnancy (never, former, during pregnancy), age at the early adolescence visit, age at blood draw for DNA methylation, and cell type proportions. Batch effect from plate was adjusted in ComBat. BMIz was included in the ComBat model to protect regression variability;

e ‘% TE’ denotes the proportion of total effect explained by each mediator, calculated as α*β/TE. In this study, higher BMIz in mid-childhood is associated with higher cardio-metabolic risk score in early adolescence.